Iovance Biotherapeutics
IOVA
IOVA
226 hedge funds and large institutions have $970M invested in Iovance Biotherapeutics in 2023 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 106 increasing their positions, 52 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
226
Holders Change
+8
Holders Change %
+3.67%
% of All Funds
3.6%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
41
Increased
106
Reduced
52
Closed
31
Calls
$33.7M
Puts
$16.2M
Net Calls
+$17.4M
Net Calls Change
+$12.4M
Top Buyers
| 1 |
MFM
MHR Fund Management
New York
|
$91M |
| 2 |
Millennium Management
New York
|
$35.6M |
| 3 |
State Street
Boston,
Massachusetts
|
$76.1M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
$20.4M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
$18.1M |
